Over the last 12 months, Orchestra BioMed Holdings insiders reported 6 buys totaling $143K and 5 sales totaling $258K across SEC Form 4 filings. 36% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Hochman David PSee Remarks · O·D | ▲ Buy | 10,000 | $4.79 | $48K | +0.9% | — |
| Sep 1, 2026 | Sherman DarrenSee Remarks · O·D | ▼ Sale | 15,000 | $4.94 | $74K | -1.3% | plan |
| Aug 26, 2026 | Sherman DarrenSee Remarks · O·D | ▲ Buy | 2,000 | $5.33 | $11K | — | indirect |
| Aug 3, 2026 | Sherman DarrenSee Remarks · O·D | ▼ Sale | 15,000 | $4.09 | $61K | -1.3% | plan |
| Jul 1, 2026 | Sherman DarrenSee Remarks · O·D | ▼ Sale | 15,000 | $4.27 | $64K | -1.3% | plan |
| Jun 1, 2026 | Hochman David PSee Remarks · O·D | ▲ Buy | 5,000 | $3.83 | $19K | +0.5% | — |
| Jun 1, 2026 | Sherman DarrenSee Remarks · O·D | ▼ Sale | 15,000 | $3.87 | $58K | -1.3% | plan |
| Apr 27, 2026 | RTW INVESTMENTS, LP10% | ▼ Sale | 32 | $4.13 | $132 | — | indirect |
| Mar 13, 2026 | Hochman David PSee Remarks · O·D | ▲ Buy | 10,000 | $4.29 | $43K | +0.9% | — |
| Nov 14, 2025 | Hochman David PSee Remarks · O·D | ▲ Buy | 5,000 | $4.07 | $20K | +0.8% | — |
| Sep 19, 2025 | Aryeh JasonD | ▲ Buy | 1,000 | $2.45 | $2K | +0.9% | — |
| Aug 25, 2025 | Fain Eric SD | ▲ Buy | 5,760 | $2.61 | $15K | +8.7% | indirect |
| Aug 25, 2025 | Sherman DarrenSee Remarks · O·D | ▲ Buy | 3,000 | $2.62 | $8K | +0.3% | — |
| Aug 25, 2025 | Taylor Andrew LawrenceChief Financial Officer · O | ▲ Buy | 2,000 | $2.55 | $5K | +0.4% | — |
| Aug 21, 2025 | Hochman David PSee Remarks · O·D | ▲ Buy | 6,000 | $2.49 | $15K | +0.9% | — |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Orchestra BioMed Holdings filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $OBIO feed.